Recognition
[용어속성] Term
Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study
Research
[키워드] 95% CI
95% confidence interval
Acute kidney injury
admitted to ICU
age
AKI
AKI patient
association
baseline characteristics
Care
Chronic kidney disease
CKD
Clinical course
cohort study
Coronavirus disease-19
COVID-19
COVID-19 patient
Critically ill patient
dialysis
discharge
Factor
Follow-up
hazard ratio
help
hospital discharge
ICU
ICU admission
identify
incidence
Infection
initiated
intensive care
Kidney injury
kidney replacement therapy
London
male
management
mechanical ventilation
Mortality
occurred
organ support
outcome
Patient
patients
positive
Prevalence
prevalent
progression
protective effect
Recognition
recovery
reduction in
renal
renal function
Result
retrospective
risk
risk factor
SARS-CoV-2
subsequent
supplementary material
survival
survivor
therapy
United Kingdom
was performed
[DOI] 10.1186/s13613-021-00914-5 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13613-021-00914-5 PMC 바로가기 [Article Type] Research
Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
SARS-COV-2 스파이크 단백질에서의 시그니처 중화 항체로의 탈출
Research Article
[키워드] ACE2
ACE2 binding
ACE2 receptor
Affect
Alter
Amino acid
amino acid substitution
amino acids
Analysis
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
antibodies
antibody
Antibody neutralization
binding
Cell
changes in
circulating
Combination
convalescent
core
COVID-19
Critical
Determining
develop
diagnostics
E484K
elicited
engage
enzyme
evade
Evolution
explanation
grid
Host
host immunity
hotspot
identify
Immune escape
immune escape mutants
immune evasion
in silico
increase
Infection
Interaction
K417N
lentivirus
MONITOR
Mutation
mutations
N501Y
Neutralizing antibodies
neutralizing antibody
neutralizing capacity
Neutralizing-antibody
Pandemics
Protein
provide
provided
pseudotyped lentiviruses
Recognition
reduce
responses
SARS-CoV-2
SARS-CoV-2 antibody
SARS-CoV-2 evolution
SARS-COV-2 infection
SARS-CoV-2 spike protein
SARS-CoV-2 virus
SARS-CoV2
sera
shown
signature
specificity
Spike protein
target
targets
tested
the spike protein
Therapies
understanding
vaccination
Vaccine
variants
variants of concern
Viral
Viral protein
virion
virus
[DOI] 10.1371/journal.ppat.1009772 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.ppat.1009772 PMC 바로가기 [Article Type] Research Article
Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19
COVID-19의 급성 및 회복기 환자에서 SARS-CoV-2 막 단백질에 대한 항체 반응
Immunology
[키워드] acute disease
acute phase
Amino acid
amino acids
antibodies
antibody
antibody reactivity
Antibody Response
B-cell epitope mapping analyses
Complete
convalescent phase
Course
COVID-19
COVID-19 antibody
COVID-19 patients
disease
ELISA
epitope
Epitopes
fusion protein
historical control
IgM
IgM response
immunodominant
immunodominant epitopes
linear epitope
longitudinal analysis
M protein
membrane
membrane protein
N- and C-termini
N-terminus
nucleocapsid protein
overlap
Patient
peptide
peptides
phase
plasma samples
Protein
raised
RBD
reactivity
Recognition
response
SARS-CoV-2
SARS-CoV-2 protein
SARS-CoV-2 proteins
Serological assay
serological assays
Seropositivity
significantly lower
specific antibodies
synthetic peptide
the antibody response
the SARS-CoV-2
understanding
Vaccines
[DOI] 10.3389/fimmu.2021.679841 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.679841 PMC 바로가기 [Article Type] Immunology
Do Anti-androgens Have Potential as Therapeutics for COVID-19?
항안드로겐이 COVID-19 치료제로 가능성이 있습니까?
Article
[키워드] ACE2
acting
Activation
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
amplification
androgen
Androgen receptor
androgens
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
Anti-androgen
anti-androgens
attachment
Cancer cells
Cell
cells
characterized
cleavage
clinical trial
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 severity
Deprivation
exhibiting
expression
followed by
Gender
glycoprotein
Hospitalization
Hypothesis
increase
infect
Infection
limitation
lung
male
men
mitigate
molecular
mortality rate
offer
patients
Perspective
Potential
Prostate cancer
protease
receptor
Recognition
reducing
responsible
SARS-CoV-2
Serine
serine 2
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe COVID-19
severity
Sex
sex differences
spike glycoprotein
Spike protein
susceptibility
Testosterone
Therapeutics
therapy
TMPRSS2
TMPRSS2 expression
transmembrane
transmembrane protein
viral spike
virus
women
[DOI] 10.1210/endocr/bqab114 PMC 바로가기 [Article Type] Article
[DOI] 10.1210/endocr/bqab114 PMC 바로가기 [Article Type] Article
Relevance of BET Family Proteins in SARS-CoV-2 Infection
Review
[키워드] acute respiratory syndrome
Analysis
animal model
BET
BET inhibitors
BRD2
BRD4
bromodomain
caused
cell cycle progression
cellular
chromatin
coronavirus
coronavirus disease
COVID-19
death
disease
domain
drug
E protein
family
groups
immune response
Immunity
Infection
Inflammation
interact
mimicking
pandemic
Protein
Proteins
proteomic
Recognition
Relevance
SARS-CoV-2
SARS-COV-2 infection
structural protein
target
terminal
therapeutic intervention
Transcription
variety
virus
viruses
[DOI] 10.3390/biom11081126 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/biom11081126 PMC 바로가기 [Article Type] Review
Scent dog identification of SARS-CoV-2 infections in different body fluids
다른 체액에서 SARS-COV-2 감염의 향기 개 확인
Randomized Controlled Trial
[키워드] 95% CI
Beta
beta-propiolactone
body fluid
body fluids
breath
cognitive
Compound
detect
diagnostic
diagnostic sensitivity
dog
double-blind
experiment
inactivated
indicate
randomised
Recognition
released
Result
Saliva
SARS-CoV-2
SARS-CoV-2 infected individuals
SARS-COV-2 infection
SARS-CoV-2 infections
SARS-CoV-2 pandemic
Scent
Scent detection dogs
sensitivity
Sensitivity and specificity
specificity
subsequent
supplementary material
Support
Sweat
Symptoms
tested
tracing
transfer
Urine
vaccination
Volatile organic compounds
[DOI] 10.1186/s12879-021-06411-1 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1186/s12879-021-06411-1 PMC 바로가기 [Article Type] Randomized Controlled Trial
Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients
Article
[키워드] Admission
Biomarkers
control group
correlated
COVID-19
cytokine
Cytokines
Deceased
domain
enrolled
expression
Gene Expression
IL-18
Infection
Innate immunity
interferon
Lower
lower expression
mechanical ventilation
mRNA
outcome
overexpression
Patient
pattern
Peripheral blood
peripheral blood cell
plasma
receptor
Recognition
respiratory
severe COVID-19
severe COVID-19 patient
supplementary oxygen
survived
TLR3
TLR4
TLRs
Toll-like receptor
Toll-like receptor 3
was determined
World Health Organization
[DOI] 10.1038/s41598-021-94624-4 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-021-94624-4 PMC 바로가기 [Article Type] Article
Structural Basis for SARS-CoV-2 Nucleocapsid Protein Recognition by Single-Domain Antibodies
Immunology
[키워드] Affect
antibody
antigen tests
Basis
binding affinity
binding domain
C-terminal
caused
circulating SARS-CoV-2 variants
conserved
coronavirus SARS-CoV-2
COVID-19 pandemic
detect
develop
diagnostic test
diagnostics
domain
effective vaccine
high affinity
high-resolution crystal structure
infections
N-terminal
nanobodies
nucleocapsid (N) protein
phase separation
Protein
public health
Recognition
recognize
recognizing
RNA
RNA binding
SARS-CoV-2
SARS-CoV-2 infections
the SARS-CoV-2
while
X-ray crystallography
[DOI] 10.3389/fimmu.2021.719037 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.719037 PMC 바로가기 [Article Type] Immunology
SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity
SARS-COV-2 N 단백질은 타고난 면역을 억제하기 위해 TRIM25- 매개 RIG-I 활성화를 표적으로합니다.
Article
[키워드] accessory proteins
Activation
Affect
affecting
antagonistic
characterized
clinical picture
contributing to
counteract
COVID-19
Cytokines
decrease
demonstrated
domain
ENCODE
exacerbated
expressed
feature
host immune system
IFN
Infection
Innate
innate immune response
Innate immunity
Interaction
involved
Mask
mechanism
molecular mechanism
molecular mechanisms
N protein
novel SARS-CoV-2 virus
occurred
Pathways
Pattern recognition
pattern recognition receptor
pro-inflammatory cytokine
pro-inflammatory cytokines
Protein
PRR
Recognition
reported
RIG-I
RIG-I activation
SARS-CoV-2
SARS-CoV-2 N
SARS-CoV-2 N protein
SARS-CoV-2 virus
secretion
signaling pathways
suppresse
target
the N protein
the SARS-CoV-2
TRIM25
Viral
viral pathogenesis
[DOI] 10.3390/v13081439 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v13081439 PMC 바로가기 [Article Type] Article